Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Antibody Analytics is teaming with Science Exchange to offer its surface plasmon resonance services to a global research community.
A trio of aging-focused biotechs and research firms formed a joint venture to develop small molecules for a novel target hoping to extend life spans.
Japan-based Modulus Discovery raised $7.2 million in series A funds that will be used to bolster its R&D platform efforts.
Charles River Labs reported that second-quarter revenues soared 24.8% on support from recent acquisitions and a favorable foreign currency environment.
Syneos Health, a combo CRO/CCO, said it plans to make a secondary stock offering of 6 million shares priced to the public at $50.15 per share.
Premier Research, a global CRO, acquired Regulatory Professionals and will merge the firm into a new division.
Novartis will partner with Albumedix to explore using the company’s technology as a possible drug delivery platform for several therapies.
Clinical research helper WIRB-Copernicus Group has acquired KMR Group and Metrics Consortium to bolster its market insights and intelligence division.
Healx has reeled in $10 million in series A funding it plans to use to hire more researchers and enhance its AI platform.
Pharma giant Novartis has signed Shyft, a Medidata Solutions subsidiary, to help strengthen its digital solutions.